Widely used:
Analyst’s Choice
Recently Viewed
Clear All
Value Research Rating
Analyst’s Choice
Riskometer
Very High
₹38.2930 -0.21%
As on 06-Dec-2024
As per SEBI's Riskometer.
Split between different types of investments
Split between categories of Equity investments
Rating |
VR Opinion |
Risk
|
Return (%) |
|
Expense Ratio (%)
|
|
|---|---|---|---|---|---|---|
|
Mirae Asset Healthcare Fund - Regular Plan
|
|
|
Very High
|
loading... |
1.93 |
|
 |
|
Very High
|
loading... |
1.92 |
||
 |
|
Very High
|
loading... |
1.95 |
||
|
|
Very High
|
loading... |
2.14 |
||
|
|
Very High
|
loading... |
1.81 |
₹2,770 Cr
1.00 (365)
5,000
--
99
5
Investment Strategy
The scheme seeks to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly in Healthcare and allied sectors in India.
Suitability
This is a fund that invests mainly in shares of pharmaceutical and healthcare companies.
We believe that investors should avoid funds that have a narrowly defined investment mandate such as this one. Instead, they should invest in flexi-cap funds which provide complete freedom to the fund management team to invest in companies from which it expects maximum gains.
But if you do invest, you must do so only through the SIP route. Click here to read a primer on SIP investing.
Warning: Do not invest in this, or any other pharma sector fund, if you need to redeem your investment in less than seven years.
Capital Gains Taxation
Disclaimer: The tax information has been prepared on a best-effort basis using information available in the public domain and other sources that Value Research considers reliable. This is not meant as tax advice, and we advise you to consult your tax advisor before making any decision. Value Research takes no responsibility and assumes no liability for any loss or damage arising from any investment or redemption decision based on this information.
Dividend Taxation
Mirae Asset Healthcare Fund - Regular Plan is mandated to invest at least 80 per cent of its assets in the shares of pharmaceutical and healthcare companies.
Mutual funds can be bought directly from the website of the fund house. For instance, Mirae Asset Healthcare Fund - Regular Plan fund can be purchased from the website of Mirae Asset Mutual Fund. You can also buy mutual funds through platforms like MF Central, MF Utility, among others. However, if you are not comfortable buying mutual funds online, you can seek help of a mutual fund distributor. Most banks also act as mutual fund distributors. So you can connect with your bank for assistance.
The NAV of Mirae Asset Healthcare Fund - Regular Plan is ₹38.2930 as of 09-Dec-2024.
The AUM of Mirae Asset Healthcare Fund - Regular Plan Fund is ₹2,770 Cr as of 31-Oct-2024
The riskometer level of Mirae Asset Healthcare Fund - Regular Plan is Very High. See More
| Company | Percentage of Portfolio |
|---|---|
|
12.00
|
|
|
8.05
|
|
|
6.80
|
|
|
6.20
|
|
|
6.05
|
As of 31-Oct-2024, Mirae Asset Healthcare Fund - Regular Plan had invested 99.08% in Equity, 0.91% in Cash & Cash Eq. and 0.01% in Debt See More
Mirae Asset Healthcare Fund - Regular Plan is 6 years 5 months old. It has delivered 23.20% returns since inception. See More
|
1Y
|
3Y
|
5Y
|
7Y
|
10Y
|
Since Inception
|
|---|---|---|---|---|---|
|
39.72%
|
19.28%
|
28.83%
|
--
|
--
|
23.20%
|
No, There is no lock in period in Mirae Asset Healthcare Fund - Regular Plan.
The expense ratio of Mirae Asset Healthcare Fund - Regular Plan is 1.93.
